The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 19 April 2004. doi:10.1084/jem.20031557
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 199, Number 8, 1121-1131
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 609K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aprahamian, T.
Right arrow Articles by Walsh, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aprahamian, T.
Right arrow Articles by Walsh, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Impaired Clearance of Apoptotic Cells Promotes Synergy between Atherogenesis and Autoimmune Disease

Tamar Aprahamian1,3, Ian Rifkin2, Ramon Bonegio2, Bénédicte Hugel4, Jean-Marie Freyssinet4, Kaori Sato1, John J. Castellot, Jr.3, and Kenneth Walsh1,3

1 Molecular Cardiology, Whitaker Cardiovascular Institute
2 Renal Section, Department of Medicine, Boston University School of Medicine, Boston, MA 02118
3 Department of Anatomy and Cellular Biology, Program in Cellular, Molecular, and Developmental Biology, Tufts University School of Medicine, Boston, MA 02111
4 Institut d'Hématologie et d'Immunologie, Faculté de Médecine, Université Louis Pasteur, 67085 Strasbourg et Institut National de la Santé et de la Recherche Médicale, U143, 94276 Le Kremlin-Bicetre, France

Address correspondence to Kenneth Walsh, Molecular Cardiology, Whitaker Cardiovascular Institute, Boston University School of Medicine, 715 Albany St., W611, Boston, MA 02118. Phone: (617) 414-2392; Fax: (617) 414-2391; email: kwalsh{at}world.std.com

To clarify the link between autoimmune disease and hypercholesterolemia, we created the gld.apoE–/– mouse as a model of accelerated atherosclerosis. Atherosclerotic lesion area was significantly increased in gld.apoE–/– mice compared with apoE–/– mice. gld.apoE–/– mice also displayed increases in lymphadenopathy, splenomegaly, and autoantibodies compared with gld mice, and these effects were exacerbated by high cholesterol diet. gld.apoE–/– mice exhibited higher levels of apoptotic cells, yet a reduced frequency of engulfed apoptotic nuclei within macrophages. Infusion of lysophosphatidylcholine, a component of oxidized low density lipoprotein, markedly decreased apoptotic cell clearance in gld mice, indicating that hypercholesterolemia promotes autoimmune disease in this background. These data suggest that defects in apoptotic cell clearance promote synergy between atherosclerotic and autoimmune diseases.

Key Words: atherosclerosis • autoimmunity • macrophages • lysophosphatidylcholine • lymphoproliferation


Abbreviations used in this paper: aCL, anticardiolipin antibody; ANA, antinuclear antibody; LDL, low density lipoprotein; LPC, lysophosphatidylcholine; oxLDL, oxidized LDL; TUNEL, TdT-mediated dUTP nick-end labeling; VLDL, very LDL.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS